All States › New York › New York County › Linda Rosenthal › Evidence
Neutral Bill Mar 16, 2026

Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.

Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.

https://legiscan.com/NY/bill/A09010/2025
Bill data from LegiScan, used under CC BY 4.0.
Linda Rosenthal Assemblymember
Share on X Share on Facebook
← Back to Linda Rosenthal's profile
{# E23 (Nick, ruling section 1 answer 10): quoting a bill or a court opinion works the way quoting a news article works. Select a passage above and the same panel opens: the passage goes to the official you choose, with this document's own address as its source and its own type. #}